We seek to leverage #CRISPR/Cas9 #genomeediting to create next-gen engineered cells that can treat oncological and immunological diseases for which there are currently limited to no treatment options available. Learn more about our #celltherapy approach: https://t.co/nBykDZAt8f https://t.co/m09Ju8saTh